Skip to main content

Wyeth Renews, Expands License to Ingenuity's Pathway Analysis Software

NEW YORK  (GenomeWeb News) — Ingenuity Systems today said that Wyeth Pharmaceuticals has extended and expanded a licensing agreement for its Pathway Analysis software.
 
Wyeth’s researchers will use the IPA software to study pharmacogenomic biomarkers and other areas, Ingenuity said.
 
Ingenuity said Wyeth has been using its software since 2003.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.